{
  "ticker": "CAH",
  "company": "Cardinal Health Inc.",
  "filing_type": "10-K",
  "year_current": "2026",
  "year_prior": "2025",
  "summary": {
    "added": 26,
    "removed": 34,
    "modified": 108,
    "unchanged": 40,
    "total_current": 174,
    "total_prior": 182
  },
  "source": "SEC EDGAR",
  "url": "https://riskdiff.com/cah/2026-vs-2025/",
  "markdown_url": "https://riskdiff.com/cah/2026-vs-2025/index.md",
  "json_url": "https://riskdiff.com/cah/2026-vs-2025/index.json",
  "access": "public_preview",
  "source_filings": [
    {
      "label": "2026 10-K filing on SEC EDGAR",
      "url": "https://www.sec.gov/Archives/edgar/data/721371/000072137126000038/0000721371-26-000038-index.htm"
    },
    {
      "label": "2025 10-K filing on SEC EDGAR",
      "url": "https://www.sec.gov/Archives/edgar/data/721371/000072137125000079/0000721371-25-000079-index.htm"
    }
  ],
  "generated": "2026-09-28",
  "ai_summary": "Extensive revisions add financial-instrument, tax, software-system and divestiture risks while removing a product-quality warning, shifting emphasis rather than clearly raising or lowering overall risk.",
  "ai_brief": {
    "executive_summary": "Extensive revisions add financial-instrument, tax, software-system and divestiture risks while removing a product-quality warning, shifting emphasis rather than clearly raising or lowering overall risk.",
    "direction": "mixed",
    "top_themes": [
      "Interest Rates & Inflation",
      "Regulatory & Legal",
      "Divestiture and financial reporting risks"
    ]
  },
  "risks": [
    {
      "status": "ADDED",
      "current_title": "Cash Equivalents",
      "prior_title": null,
      "severity": {
        "deterministic": 9,
        "ai_bump": 0,
        "total": 9,
        "tier": "high",
        "signal_hits": [
          "tariffs",
          "rates"
        ]
      },
      "current_body": "We consider liquid investments purchased with an initial effective maturity of three months or less to be cash equivalents. The carrying amount of cash equivalents approximates fair value. Receivables and Allowance for Doubtful AccountsTrade receivables are reported at their estimated collectible amounts and presented net of an allowance for doubtful accounts of $201 million and $213 million at June 30, 2026 and 2025, respectively. In addition to credit losses, the allowance also includes reserves related to customer disputes and late fees billed to customers, which are recognized within our consolidated statements of earnings as reductions of revenue. An account is considered past due on the first day after its due date. In accordance with contract terms, we generally have the ability to charge customers service fees or higher prices if an account is considered past due. We regularly monitor past due accounts and establish appropriate reserves to cover potential losses, and consider historical experience, pricing discrepancies, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop our allowance for credit losses. We review these factors quarterly to determine if any adjustments are needed to the allowance. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.We provide financing to various customers. Such financing arrangements range from 1 year to 5 years at interest rates that are generally subject to fluctuation. Interest income on these arrangements is recognized as it is earned. The financings may be collateralized, guaranteed by third parties or unsecured. Finance notes, net and related accrued interest were $28 million (current portion $3 million) and $32 million (current portion $7 million) at June 30, 2026 and 2025, respectively, and are included in other assets (current portion is included in prepaid expenses and other) in the consolidated balance sheets. Finance notes receivable allowance for doubtful accounts were $7 million and $2 million at June 30, 2026 and 2025, respectively. We estimate an allowance for these financing receivables based on historical collection rates and the creditworthiness of the customer. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.Other Receivables Since February 2025, we have paid approximately $200 million in International Emergency Economic Powers Act (\"IEEPA\") tariffs, related to products that we source, manufacture or distribute, primarily in our GMPD segment.During the fourth quarter of fiscal 2026, we recorded a receivable of approximately $200 million in relation to the expected refund of IEEPA tariffs from the government, which is included in prepaid expenses and other assets in the consolidated balance sheet. Upon receiving refunds of IEEPA tariffs from the government, we expect to return to those customers the portion of those refunds that reflect the estimated increased prices paid related to IEEPA tariffs."
    }
  ],
  "full_url": "https://riskdiff.com/cah/2026-vs-2025/full/"
}